JX-594 recombinant vaccina GM-CSF

BIOLOGICAL2 trials

Sponsors

Jennerex Biotherapeutics

Conditions

HCCHepatocellular CarcinomaHepatocellular CarinomaLiver Cancer

Phase 2

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

CompletedNCT01387555

Jennerex BiotherapeuticsHCC, Hepatocellular Carcinoma, Liver Cancer

Start: 2011-10-08End: 2013-10-01Updated: 2026-07-08

A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

CompletedNCT01636284

Jennerex BiotherapeuticsHepatocellular Carinoma

Start: 2012-06-30End: 2013-06-30Updated: 2021-01-20

Related Papers

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

OncoImmunology2019-06-03125 citations